UBE2C upregulation has been found correlated with poor overall survival (OS) and progression-free survival (PFS) in patients with NSCLC [27], and our study indicated that PTTG1 may be associated with the UBE2C signaling pathways in kidney renal clear cell carcinoma. The gene discussed is UBE2C; the disease is non-small cell lung carcinoma.